McCarthy Tétrault advised Feldan on the deal.Feldan Bio Inc. (“Feldan”) completed a C$16.5 million Series B investment round that will see new investors Investissement Québec, Amgen…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
